Midgard Science

Labs / CDMO: development & manufacturing

AP

Aboleris Pharma

Gosselies, Belgium · aboleris-pharma.com

Aboleris Pharma is a clinical-stage biopharmaceutical company developing therapies to restore immune tolerance for autoimmune diseases and organ transplantation rejection. It is based in Gosselies, Belgium, and Nantes, France.

They take quote requests by email.

What they offer

  • Development of anti-CD45RC antibody therapies

    Develops a novel class of antibodies targeting CD45RC to selectively deplete pathogenic Effector T and B cells while preserving Regulatory cells.

  • Immune tolerance therapeutics

    Develops curative-intent therapies designed to reset the immune system and restore immune tolerance.

What they work on

Modalities
Small molecule, Antibody, Cell therapy
Therapeutic areas
autoimmune diseases, organ transplantation rejection, rheumatoid arthritis, inflammatory bowel disease, graft-versus-host disease, Sjögren's disease
Sites
Gosselies, Belgium · Nantes, France
Founded
2015

Similar labs. CDI Labs, Esco Aster, Evotec, JPT Peptide Technologies

Found in a contract services directory. Listing built from aboleris-pharma.com. Work here? Claim this listing.

Aboleris Pharma · Midgard Science